Filing Details
- Accession Number:
- 0001731122-18-000190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-28 19:11:31
- Reporting Period:
- 2018-12-28
- Accepted Time:
- 2018-12-28 19:11:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527728 | Enochian Biosciences Inc | ENOB | Pharmaceutical Preparations (2834) | 452259340 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709513 | Rene Sindlev | Stumpedyssevej 17 Copenhagen G7 2100 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-27 | 92,968 | $8.00 | 5,115,137 | No | 4 | P | Indirect | By RS Bio ApS |
| Common Stock | Acquisiton | 2018-12-27 | 1,307,693 | $1.30 | 6,422,830 | No | 4 | X | Indirect | By RS Bio ApS |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By RS Bio ApS |
| No | 4 | X | Indirect | By RS Bio ApS |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant to Purchase Common Stock | Disposition | 2018-12-27 | 1,307,693 | $1.30 | 1,307,693 | $1.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,092,307 | 2017-05-15 | 2022-04-21 | No | 4 | X | Indirect |
Footnotes
- ApS assigned its holdings in Enochian Biosciences, Inc. to RS Bio ApS. Both entities are wholly owned by Rene Sindlev.
Billionaire Hedge Funds
